Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea
· Delayed Price · Currency is KRW 3,605.00
+80.00 (2.27%)
Apr 1, 2025, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 76.08 billion as of April 1, 2025. Its market cap has increased by 38.43% in one year.
Market Cap
76.08B
Enterprise Value
80.18B
Revenue
4.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,605.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 76.08B, a decrease of -84.23%. That is a compound annual growth rate of -26.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.66T |
| Celltrion | 38.03T |
| ALTEOGEN | 18.79T |
| Yuhan | 8,537.79B |
| SK Biopharmaceuticals | 7,893.98B |
| HLB Co., Ltd. | 7,500.72B |
| Sam Chun Dang Pharm. | 3,930.51B |
| PharmaResearch | 3,506.51B |